Is Humana Inc. (HUM) The Top Falling Stock with Unusual Volume?

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against other top falling stocks with unusual volume.

Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling. While some stocks have come under pressure due to the above two reasons, others have simply followed the market direction or have dipped for company-specific reasons.

Regardless of the reasons for stocks going down, falling stocks provide an opportunity for fresh investors to get in at good prices. Once the risks subside, these stocks usually recover quickly as well. We decided to uncover these stocks and see if it makes sense to put money in them to take advantage of the ongoing market turmoil.

To come up with our list of top 20 stocks falling with unusual volume, we looked at stocks over $300 million in market cap, their one-week performance, and used relative volume to detect the unusual volume activity.

Relative volume compares the daily volume to the three-month average trading volume of the stock, making it easy to detect spikes in volume. These spikes usually signal something important is happening, which, when combined with falling prices, becomes a red flag that investors can’t ignore.

Is Humana Inc. (HUM) The Top Falling Stock with Unusual Volume?

A closeup of an elderly patient happily receiving a specialty healthcare product.

Humana Inc. (NYSE:HUM)

Humana Inc. is a medical and specialty insurance products provider. The company operates through the CenterWell and Insurance segments. It provides supplemental benefit plans and medical care to individuals. The stock is down 8.88% in a week on a relative volume of 2.15.

After falling during the last week, the stock has come back to the same level it was at earlier in the month when some positive developments caused the price to spike. The company received a favorable policy decision from the CMS for next year’s Medicare Advantage plans. However, there are still question marks on the company’s long-term ability to generate profits.

Regulatory issues and healthcare spending are two big hurdles that the company needs to figure out. Medicare and Medicaid are two major reasons for the government’s out-of-control spending, and these will likely stay under pressure during this presidential term. The long-term prospects of Humana, therefore, look bleak.

Overall, HUM ranks 9th on our list of top falling stocks with unusual volume. While we acknowledge the potential of HUM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than HUM but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.